Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-11-03

FDA Approved: BACLOFEN — Supplemental Application (Northstar RxLLC)

View source ↗

Summary

The FDA approved a supplemental application for baclofen from Northstar RxLLC, finalizing changes to an approved generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)